PREFERENTIAL METABOLIC-ACTIVATION OF SUBCORTICAL BRAIN-AREAS BY ACUTE ADMINISTRATION OF NICOTINE TO RATS

被引:45
作者
MCNAMARA, D [1 ]
LARSON, DM [1 ]
RAPOPORT, SI [1 ]
SONCRANT, TT [1 ]
机构
[1] NIA,NEUROSCI LAB,BETHESDA,MD 20205
关键词
arecoline; cerebral metabolism; deoxyglucose; nicotine;
D O I
10.1038/jcbfm.1990.7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cerebral metabolic and behavioral effects of acutely administered nicotine were measured in rats in relation to dose. Nicotine 0.1, 1, or 10 mg/kg or vehicle was administered intraperitoneally to 3-months-old male Fischer-344 rats that had been pretreated with hexamethonium bromide 5 mg/kg i.p. to reduce peripheral autonomic effects. Regional CRM(glc) (rCMR(glc)) values were measured using the quantitative autoradiographic [14C]-2-deoxy-D-glucose method, in 71 brain regions, beginning 3 min after nicotine or vehicle administration. Intensity of body tremor, scored by a blinded rater, was dose related and peaked at 3 min after nicotine injection. rCMR(glc) rose in a dose-related manner: Nicotine 0.1 mg/kg had no significant effect in any region, whereas 1 mg/kg elevated rCMR(glc) significantly in 21 regions (mean rise 20%) and 10 mg/kg produced generalized (56 regions) and greater (mean rise 50%) increases in rCMR(glc). Nicotine 1 mg/kg activated thalamic nuclei, cerebellum, geniculate nuclei, superior colliculus, median raphe, reticular formation, and the habenulointerpeduncular pathway, but was without effect in the telencephalon. Effects of nicotine in the hindbrain were related anatomically to reported distributions of [3H] nicotine and [3H]acetylcholine but not [125I]α-bungarotoxin binding sites, implying that the former ligands label functional nicotine receptors. The pattern of change in rCMR(glc) after nicotine administration suggests that its cognitive effects in humans are due to augmented arousal/attention and visual processing rather than to direct neocortical or hippocampal activation.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 46 条
[1]   EFFECTS OF SINGLE INJECTIONS OF NICOTINE ON THE ASCENDING DOPAMINE PATHWAYS IN THE RAT - EVIDENCE FOR INCREASES OF DOPAMINE TURNOVER IN THE MESOSTRIATAL AND MESOLIMBIC DOPAMINE NEURONS [J].
ANDERSSON, K ;
FUXE, K ;
AGNATI, LF .
ACTA PHYSIOLOGICA SCANDINAVICA, 1981, 112 (03) :345-347
[2]   NICOTINE-INDUCED RELEASE OF CATECHOLAMINES FROM RAT HIPPOCAMPUS AND STRIATUM [J].
ARQUEROS, L ;
NAQUIRA, D ;
ZUNINO, E .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (23) :2667-2674
[3]  
BIEN E, 1983, Acta Physiologica Polonica, V34, P227
[4]  
CHIOU CY, 1970, ARCH INT PHARMACOD T, V187, P88
[5]  
CLARKE PBS, 1985, J NEUROSCI, V5, P1307
[6]   THE PHARMACOLOGY OF CHOLINERGIC EXCITATORY RESPONSES IN HIPPOCAMPAL PYRAMIDAL CELLS [J].
COLE, AE ;
NICOLL, RA .
BRAIN RESEARCH, 1984, 305 (02) :283-290
[7]  
COSTA LG, 1983, J PHARMACOL EXP THER, V226, P392
[8]   LOCAL CHANGES IN CEREBRAL GLUCOSE-UTILIZATION DURING KETAMINE ANESTHESIA [J].
CROSBY, G ;
CRANE, AM ;
SOKOLOFF, L .
ANESTHESIOLOGY, 1982, 56 (06) :437-443
[9]   NEW TABLES FOR MULTIPLE COMPARISONS WITH CONTROL [J].
DUNNETT, CW .
BIOMETRICS, 1964, 20 (03) :482-&
[10]   CHARACTERIZATION OF L-[H-3]NICOTINE BINDING IN HUMAN CEREBRAL-CORTEX - COMPARISON BETWEEN ALZHEIMERS-DISEASE AND THE NORMAL [J].
FLYNN, DD ;
MASH, DC .
JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) :1948-1954